Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-22
DOI
10.3389/fimmu.2021.640935
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Administration of CD4+CD25highCD127−FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study
- (2021) Kamil Chwojnicki et al. BIODRUGS
- Antigen-specific therapeutic approaches for autoimmunity
- (2019) Pau Serra et al. NATURE BIOTECHNOLOGY
- Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
- (2019) Irati Zubizarreta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
- (2019) Ester Cantó et al. JAMA Neurology
- Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity
- (2019) Lawrence Steinman et al. CURRENT OPINION IN IMMUNOLOGY
- Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
- (2018) Jeremy Chataway et al. NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases
- (2018) Maria Grazia Roncarolo et al. IMMUNITY
- GDP-l-fucose synthase is a CD4+ T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis
- (2018) Raquel Planas et al. Science Translational Medicine
- The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-αand IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients
- (2016) Yakov Lomakin et al. MEDIATORS OF INFLAMMATION
- CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
- (2016) Alexey Belogurov et al. Neurotherapeutics
- Anoctamin 2 identified as an autoimmune target in multiple sclerosis
- (2016) Burcu Ayoglu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunology of Multiple Sclerosis
- (2016) Mireia Sospedra et al. SEMINARS IN NEUROLOGY
- Regulatory plasma cells
- (2015) Simon Fillatreau CURRENT OPINION IN PHARMACOLOGY
- A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
- (2014) Zoe Hunter et al. ACS Nano
- From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets
- (2014) Van Duc Dang et al. CURRENT OPINION IN IMMUNOLOGY
- Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells
- (2014) Patrick Peschl et al. Multiple Sclerosis Journal
- Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
- (2013) A. Lutterotti et al. Science Translational Medicine
- Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
- (2013) Agata Walczak et al. JAMA Neurology
- High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients
- (2012) Eric W. Loo et al. CELLULAR IMMUNOLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial
- (2012) Dimitrios Karussis et al. PLoS One
- Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis
- (2011) K. Raddassi et al. JOURNAL OF IMMUNOLOGY
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Immune regulation of multiple sclerosis by transdermally applied myelin peptides
- (2010) Maciej Juryńczyk et al. ANNALS OF NEUROLOGY
- Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
- (2010) L. Grau-López et al. EUROPEAN JOURNAL OF NEUROLOGY
- Autologous attenuated T-cell vaccine (Tovaxin®) dose escalation in multiple sclerosis relapsing–remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies
- (2009) B. Loftus et al. CLINICAL IMMUNOLOGY
- Human naive and memory CD4+T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells
- (2009) Rebekka Geiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
- (2008) Hideki Garren et al. ANNALS OF NEUROLOGY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis
- (2007) Arthur A. Vandenbark et al. IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More